Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 5, 1998, Pages 612-618

  Philipps, Jorg ^a   Radloff, Paul D ^a   Wernsdorfer, Walther ^c   Kremsner, Peter G ^a,b  

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Inst Specific Prophylaxis Trop M   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; FANSIDAR; FANSIMEF; HALOFANTRINE; MEFLOQUINE; QUINIDINE; QUININE;

ANTIMICROBIAL THERAPY; ARTICLE; DOSE RESPONSE; DRUG SENSITIVITY; ENDEMIC DISEASE; GABON; MALARIA; MALARIA CONTROL; NONHUMAN; PLASMODIUM FALCIPARUM;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031863673     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.612     Document Type: Article

References (43)

1. World Health Organization, 1996. World malaria situation in 1993. Wkly Epidemiol Rec 71: 17-24, 25-32, 37-39, 41-48.
2. White NJ, 1992. Antimalarial drug resistance: the pace quickens. J Antimicrob Chemother 30: 571-585.
3. Wernsdorter WH, Payne D, 1991. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 50: 95-121.
4. Burchard GD, Horstmann RD, Wernsdorfer WH, Dietrich M, 1984. Plasmodium falciparum-malaria: resistance to chloroquine, but sensitivity to mefloquine in the Gabon. A prospective in-vitro study. Trop Med Parasitol 35: 1-4.
5. Richard-Lenoble D, Kombila M, Martz M, Lefebre B, Chandenier J, Gray F, Billiault X, Therizol-Ferly M, 1989. Evolution de la resistance de Plasmodium falciparum a la chloroquine au Gabon entre 1984 et 1987-88. Ann Soc Belg Med Trop 69: 113-119.
6. Kremsner PG, Winkler S, Brandts C, Graninger W, Bienzle U, 1993. Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg 49: 650-654.
7. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W, 1994. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 169: 467-470.
8. Wildling E, Jenne L, Graninger W, Bienzle U, Kremsner PG, 1994. High dose chloroquine versus micronized halofantrine in chloroquine-resistant Plasmodium falciparum malaria. J Antimicrob Chemother 33: 871-875.
9. Metzger W, Mordmuller B, Graninger W, Bienzle U, Kremsner PG, 1995. Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese schoolchildren infected with chloroquine resistant malaria. J Antimicrob Chemorher 36: 723-728.
10. Winkler S, Brandts C, Wernsdorfer WH, Graninger W, Bienzle U, Kremsner PG, 1994. Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimulariuls. Trop Med Parasitol 45: 214-218.
11. Rudioff PD, Philipps J, Nkeyi M, Sturchler D, Mittelholzer ML, Kremsner PG, 1996. Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children. Am J Trop Med Hyg 55: 259-262.
12. Kremsner PG, Wildling E, Jenne L, Graninger W, Bienzle U, 1994. Comparison of micronized halofantrine with chloroquine-antibiotic combinations for treating Plasmodium falciparum malaria in adults from Gabon. Am J Trop Med Hyg 50: 790-795.
13. Brasseur P, Kouamouo J, Moyou-Somo R, Druilhe P, 1992. Multi-drug resistant falciparum malaria in Cameroon in 19871988 II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am J Trop Med Hyg 46: 8-14.
14. Brasseur P, Bibindou P, Moyou RS, Eggelte TA, Samba G, Penchenier L, 1993. Fast emergence of Plasmodium falciparum resistance to halofantrine. Lancet 341: 901-902.
15. Brasseur P, Kouamouo J, Moyou-Somo R, Druilhe P, 1992. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988 I. Stable figures of prevalence of chloroquine- and quinine- resistant isolates in the original foci. Am J Trop Med Hyg 46: 1-7.
16. Louis JP, Louis FJ, Trebucq A, Migliani R, Cot M, Hengy C, 1992. Chemoresistance of Plasmodium falciparum in central Africa. Lancet 340: 610-611.
17. Chandenier J, Ndounga M, Carme B, Gay F, Mbitsi A, Hayette MP, Stanghellini A, Ossoh JO, Baudon D, Zitsamele RC, 1995. chimiosensibilite in-vivo et in-vitro de Plasmodium falciparum a Brazzaville (Congo). Sante 5: 25-29.
18. Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdorfer WH, 1995. Malaria epidemiology in the province of Moyen Ogooue, Gabon. Trop Med Parasitol 46: 77-82.
19. Wernsdorfer WH, Wernsdorfer MG, 1995. The evaluation of in vitro tests for the assessment of drug response in Plasmodium falciparum. Mitt Osterr Ges Tropenmed Parasitol 17: 221-228.
20. Litchfield JT, Wilcoxon F, 1949. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99-113.
21. Louis JP, Gazin P, Hengy C, Gardon J, Moyroud J, Goghomu A, Owona R, Trebucq A, 1991. Surveillance de la chimiosensibilite in vivo de Plasmodium falciparum aux amino-4-quinoleines au Cameroun. Ann Soc Belg Med Trop 71: 139-141.
22. Hengy C, Garrigue G, Asissegue B, Ghogomu NA, Gazin P, Gelas H, Kouka-Bemba D, Le Bras J, Jambou R, 1989. Surveillance de la chimiosensibilite de Plasmodium falciparum a Yaounde et ses environs (Cameroun). Bull Soc Pathol Exot 82: 217-223.
23. Carme B, Moudzeo H, Mbitsi A, Sathounkazi C, Ndounga M, Brandicourt O, Gay F, Le Bras J, Gentilini M, 1990. La resistance medicamenteuse de Plasmodium falciparum au Congo. Bilan des enquetes realisees de 1985 a 1989. Bull Soc Pathol Exot 83: 228-241.
24. Mulder B, Ringwald P, Arens T, Louis F, 1994. Stabilization of chloroquine resistance in vivo of Plasmodium falciparum in Edea, south Cameroon. Trans R Soc Trop Med Hyg 88: 445.
25. Basco LK, Ringwald P, Simon F, Doury JC, Le Bras J, 1993. Evolution of chloroquine resistance in central and west Africa. Trop Med Parasitol 44: 111-112.
26. Benito A, Roche J, Molina R, Amela C, Alvar J, 1995. In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea. Am J Trop Med Hyg 53: 526-531.
27. Rojas-Rivero L, Gay F, Bustos MDG, Ciceron L, Pichet C, Danis M, Gentilini M, 1992. Mefloquine-halofantrine cross resistance in Plasmodium falciparum induced by intermittent mefloquine pressure. Am J Trop Med Hyg 47: 372-377.
28. Wernsdorfer WH, Landgraf B, Wiedermann G, Kollaritsch H, 1994. Inverse correlation of sensitivity in vitro of Plasmodium falciparum to chloroquine and mefloquine in Ghana. Trans R Soc Trop Med Hyg 88: 443-444.
29. Cowman AF, Galatis D, Thompson JK, 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr 1 gene and cross resistance to halofantrine and quinine. Proc Natl Acad Sci USA 91: 1143-1147.
30. Oduola AMJ, Milhous WK, Salako LA, Walker O, Desjardins RE, 1987. Reduced in-vitro susceptibility to mefloquine in west African isolates of Plasmodium falciparum. Lancet ii: 1304-1305.
31. Basco LK, Le Bras J, 1992. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 47: 521-527.
32. Jelinek T, Schelberg P, Loscher T, Eichenlaub D, 1995. Quinine resistant malaria acquired in East Africa. Trop Med Parasitol 46: 38-40.
33. Kremsner PG, Radloff P, Metzger W, Wildling E, Mordmuller B, Philipps J, Jenne L, Nkeyi M, Prada J, Bienzle U, Graninger W, 1995. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother 39: 1603-1605.
34. Adagu IS, Warhurst DC, Ogala WN, Abdu-Aguye I, Audu LI, Bamgbola FO, Ovwigho UB, 1995. Antimalarial drug response of Plasmodium falciparum from Zaria, Nigeria. Trans R Soc Trop Med Hyg 89: 422-425.
35. Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ, 1994. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 88: 324-327.
36. Phillips RE, Warrell DA, White NJ, 1985. Intravenous quinidine for the treatment of severe falciparum malaria. N Engl J Med 312: 1273-1278.
37. Doury JC, Ringwald P, Guelain J, Le Bras J, 1992. Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu). Trop Med Parasitol 43:197-198.
38. Hassan-Alin M, Kihamia M, Bjorkman A, Bwijo BA, Premji Z, Mtey GJB, Ashton M, 1995. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine and mefloquine. Am J Trop Med Hyg 53: 639-645.
39. Landgraf B, Kollaritsch H, Wiedermann G, Wernsdorfer WH, 1994. Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethaminc in Ghanaian schoolchildren. Trans R Soc Trop Med Hyg 88: 440-442.
40. Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygdjerg IC, 1996. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg 90: 179-181.
41. Wildling E, Winkler S, Brandts C, Jenne L, Graninger W, Wernsdorfer WH, Bienzle U, Kremsner PG, 1993. Halofantrine sensitivity. Lancet 342: 55.
42. Ringwald P, Le Bras J, Voyer C, Coulaud JP, 1990. Reduced in vitro susceptibility to halofantrine of Plasmodium falciparum in west Africa. Lancet 335: 421-422.
43. Wongsrichanalai C, Kyle Webster H, Wimonwattrawatee T, Sookto P, Chuanak N, Thimasarn K, Wernsdorfer WH, 1992. Emergence of multidrug-resistant Plasmodium falciparum in Thailand: in vitro tracking. Am J Trop Med Hyg 47: 112-116.